Cyramza

Cyramza Contraindications

ramucirumab

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma
Full Prescribing Info
Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in Description.
For patients with NSCLC, ramucirumab is contraindicated where there is tumour cavitation or tumour involvement of major vessels (see Precautions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in